EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES, ŒSTROGEN, AND PROGESTOGEN ON ANTIPLASMIN AND ANTITHROMBIN ACTIVITY
- 26 December 1970
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 296 (7687), 1329-1332
- https://doi.org/10.1016/s0140-6736(70)92358-5
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES ON SERUM-LEVELS OF α2-MACROGLOBULIN, TRANSFERRIN, ALBUMIN, AND IgGThe Lancet, 1970
- Changes in blood coagulation and fibrinolysis in women receiving oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1969
- Effect of Administration of a Combined Estrogen-Progestin Contraceptive on the Level of Individual Plasma ProteinsScandinavian Journal of Clinical and Laboratory Investigation, 1968
- Antithrombin III and DiseasesAmerican Journal of Clinical Pathology, 1967
- A Simple Method for the Preparation of a Substrate for a One-Stage Factor V AssayAmerican Journal of Clinical Pathology, 1967
- Dissociation of Esterolytic and Clotting Activities of Thrombin by Trypsin-Binding Macroglobulin.Experimental Biology and Medicine, 1966
- Studies on the Nature of the Circulating Anticoagulant Directed against Antihemophilic Factor: With Notes on an Assay for Antihemophilic FactorBlood, 1962
- The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor DeficienciesAmerican Journal of Clinical Pathology, 1961
- STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*JCI Insight, 1959
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951